These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12269625)

  • 1. Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease.
    Baumgartner CA; Sapir S; Ramig TO
    J Voice; 2001 Mar; 15(1):105-14. PubMed ID: 12269625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of vocal symptoms in Parkinson's disease: the Lee Silverman method].
    Dias AE; Limongi JC
    Arq Neuropsiquiatr; 2003 Mar; 61(1):61-6. PubMed ID: 12715021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: a comparison with an alternative speech treatment.
    Sapir S; Ramig LO; Hoyt P; Countryman S; O'Brien C; Hoehn M
    Folia Phoniatr Logop; 2002; 54(6):296-303. PubMed ID: 12417800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: a comparison with untreated patients and normal age-matched controls.
    Ramig LO; Sapir S; Fox C; Countryman S
    Mov Disord; 2001 Jan; 16(1):79-83. PubMed ID: 11215597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.
    Ramig LO; Sapir S; Countryman S; Pawlas AA; O'Brien C; Hoehn M; Thompson LL
    J Neurol Neurosurg Psychiatry; 2001 Oct; 71(4):493-8. PubMed ID: 11561033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Intensive Voice Treatment (The Lee Silverman Voice Treatment [LSVT LOUD]) in Subjects With Multiple Sclerosis: A Pilot Study.
    Baldanzi C; Crispiatico V; Foresti S; Groppo E; Rovaris M; Cattaneo D; Vitali C
    J Voice; 2022 Jul; 36(4):585.e1-585.e13. PubMed ID: 32819780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease.
    Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH
    Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.
    Ramig LO; Fox C; Sapir S
    Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.
    Sapir S; Spielman J; Ramig LO; Hinds SL; Countryman S; Fox C; Story B
    Am J Speech Lang Pathol; 2003 Nov; 12(4):387-99. PubMed ID: 14658991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Communication disorders marked with hypophonia. Indication and speech therapy through the LSVT method].
    Cabaret P; Sarfati J
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(5):325-8. PubMed ID: 20387379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of intensive voice treatment on facial expressiveness in Parkinson disease: preliminary data.
    Spielman JL; Borod JC; Ramig LO
    Cogn Behav Neurol; 2003 Sep; 16(3):177-88. PubMed ID: 14501539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intensive phonatory-respiratory treatment (LSVT) for presbyphonia: two case reports.
    Lu FL; Presley S; Lammers B
    J Voice; 2013 Nov; 27(6):786.e11-23. PubMed ID: 24119640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two forms of intensive speech treatment for Parkinson disease.
    Ramig LO; Countryman S; Thompson LL; Horii Y
    J Speech Hear Res; 1995 Dec; 38(6):1232-51. PubMed ID: 8747817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study.
    El Sharkawi A; Ramig L; Logemann JA; Pauloski BR; Rademaker AW; Smith CH; Pawlas A; Baum S; Werner C
    J Neurol Neurosurg Psychiatry; 2002 Jan; 72(1):31-6. PubMed ID: 11784821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.
    Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F
    Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory Responses to Two Voice Interventions for Parkinson's Disease.
    Richardson K; Huber JE; Kiefer B; Kane C; Snyder S
    J Speech Lang Hear Res; 2022 Oct; 65(10):3730-3748. PubMed ID: 36167066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders.
    Fox CM; Ramig LO; Ciucci MR; Sapir S; McFarland DH; Farley BG
    Semin Speech Lang; 2006 Nov; 27(4):283-99. PubMed ID: 17117354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
    Wight S; Miller N
    Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.